Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Unsettled with frequent outbreaks of rain. It feels like the unsettled weather is on a loop at present
Unsettled weather for the foreseeable future, but some respite on Saturday night
Over 10 thousand Cubs will be visiting Blackpool Pleasure Beach as part of their centenary celebrations.